Pharmacists can make clinical recommendations tailored to patients’ individual needs.
We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Atrial fibrillation, the most common cardiac arrhythmia, is strongly associated with increased morbidity and mortality and has become a major global public health challenge.
Specialty pharmacies must plan carefully to ensure compliance with new supply chain rules.
When making coverage decisions in oncology, payers find difficulties in translating evidence on treatment effect heterogeneity into coverage policies.
An extremely virulent (hypermucoviscous) strain of Klebsiella pneumoniae (K pneumoniae) that is resistant to carbapenem and colistin has been isolated for the first time from a patient in the United States.
Prior to the president's final State of the Union address, Democrats announced new plans to investigate drug prices in 2016.
The findings of the retrospective cohort study were presented in a poster at IDWeek 2019.
Helpful advice for your patients on treating bacterial skin infections.
Postoperative pain management presents a major challenge to patients and health care providers.
An Effective Treatment Plan Is Crucial for Patients with Crohn's Disease and Ulcerative Colitis.
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Here is an overview of the key Issues for hospital pharmacists.
A proposal to reduce Medicare Part B payment rates for hospitals participating in the 340B Drug Pricing Program has been approved 14-3 by the Medicare Payment Advisory Commission.
Dr. McCarry is a pharmacist with Rite Aid in Philadelphia, Pa.
The greater use of generic prescription medications has been widely advocated as a policy solution to rising healthcare costs.
The findings demonstrated that female gender, older age, and Caucasian race were the most likely predictors of opioid use in patients with JFMS.
Health care and pharmacy practices must regularly verify that their employees are not excluded from participation in Medicare, Medicaid, or other federal health programs.